Blair William & Co. IL Buys Shares of 686 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Blair William & Co. IL bought a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 686 shares of the company’s stock, valued at approximately $30,000.

Several other large investors also recently bought and sold shares of XPH. NBC Securities Inc. grew its holdings in SPDR S&P Pharmaceuticals ETF by 107,050.0% in the first quarter. NBC Securities Inc. now owns 2,143 shares of the company’s stock valued at $93,000 after purchasing an additional 2,141 shares during the last quarter. Beacon Pointe Advisors LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at $211,000. Captrust Financial Advisors grew its holdings in SPDR S&P Pharmaceuticals ETF by 9.4% in the fourth quarter. Captrust Financial Advisors now owns 5,827 shares of the company’s stock valued at $251,000 after purchasing an additional 500 shares during the last quarter. Sigma Planning Corp grew its holdings in SPDR S&P Pharmaceuticals ETF by 14.5% in the first quarter. Sigma Planning Corp now owns 5,894 shares of the company’s stock valued at $258,000 after purchasing an additional 747 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 29.0% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 8,437 shares of the company’s stock valued at $363,000 after acquiring an additional 1,899 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 2.3%

XPH opened at $45.64 on Thursday. The firm has a market cap of $164.30 million, a P/E ratio of 14.28 and a beta of 0.84. SPDR S&P Pharmaceuticals ETF has a 52 week low of $35.22 and a 52 week high of $48.76. The business’s fifty day simple moving average is $42.00 and its 200 day simple moving average is $41.95.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.